{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T00:32:04Z","timestamp":1716078724171},"reference-count":17,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.2217\/imt.14.10","type":"journal-article","created":{"date-parts":[[2014,5,9]],"date-time":"2014-05-09T16:21:31Z","timestamp":1399652491000},"page":"409-417","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["Irradiated Mononuclear Cells Express Significant\n            <i>In Vitro<\/i>\n            Cytotoxic Activity: Promise for\n            <i>In Vivo<\/i>\n            Clinical Efficacy of Irradiated Mismatched Donor Lymphocytes Infusion"],"prefix":"10.1080","volume":"6","author":[{"given":"Panagiotis","family":"Tsirigotis","sequence":"first","affiliation":[{"name":"Second Department of Internal Medicine,Medical School,National &amp; Kapodistrian University of Athens,\rGreece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor B","family":"Resnick","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation &amp; Cancer Immunotherapy Department,Hadassah-Hebrew University Medical Center,\rJerusalem,\rIsrael"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Violetta","family":"Kapsimalli","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine,Medical School,National &amp; Kapodistrian University of Athens,\rGreece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliane","family":"Dray","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation &amp; Cancer Immunotherapy Department,Hadassah-Hebrew University Medical Center,\rJerusalem,\rIsrael"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekaterini","family":"Psarra","sequence":"additional","affiliation":[{"name":"Department of Immunology &amp; Histocompatibility,Evangelismos General Hospital,\rAthens,\rGreece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simha","family":"Samuel","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation &amp; Cancer Immunotherapy Department,Hadassah-Hebrew University Medical Center,\rJerusalem,\rIsrael"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Spyridonidis","sequence":"additional","affiliation":[{"name":"Department of Hematology &amp; Bone Marrow Transplantation,Medical School,University of Patras,\rRio,\rGreece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evi","family":"Konsta","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine,Medical School,National &amp; Kapodistrian University of Athens,\rGreece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myrofora","family":"Vikentiou","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine,Medical School,National &amp; Kapodistrian University of Athens,\rGreece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reuven","family":"Or","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation &amp; Cancer Immunotherapy Department,Hadassah-Hebrew University Medical Center,\rJerusalem,\rIsrael"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimon","family":"Slavin","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation &amp; Cancer Immunotherapy Department,Hadassah-Hebrew University Medical Center,\rJerusalem,\rIsrael"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael Y","family":"Shapira","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation &amp; Cancer Immunotherapy Department,Hadassah-Hebrew University Medical Center,\rJerusalem,\rIsrael"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,5,9]]},"reference":[{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt.12.14"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2011.554811"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2012.09197.x"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1989.7.4.486"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2004.10.014"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.6.2195.bloodjournal8762195"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-472X(98)00026-5"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2012.07.003"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2012.11.005"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.3109\/07853890.2011.554430"},{"issue":"8","key":"e_1_3_3_14_1","first-page":"3735","article-title":"Successful immunotherapy of murine experimental hepatic metastases with lymphokine-activated killer cells and recombinant Interleukin 2","volume":"45","author":"Lafreniere R","year":"1985","unstructured":"Lafreniere R, Rosenberg SA. Successful immunotherapy of murine experimental hepatic metastases with lymphokine-activated killer cells and recombinant Interleukin 2. Cancer Res. 45(8),3735\u20133741 (1985).","journal-title":"Cancer Res."},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1068440"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24030"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403524"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703406"},{"issue":"1","key":"e_1_3_3_19_1","first-page":"S174","article-title":"Immunotherapy using rIL-2 activated mismatched donor lymphocytes positively selected for CD56+ for the treatment of resistant haematologic malignancies after stem cell transplantation","volume":"33","author":"Slavin S","year":"2004","unstructured":"Slavin S, Morecki S, Shapira M et al. Immunotherapy using rIL-2 activated mismatched donor lymphocytes positively selected for CD56+ for the treatment of resistant haematologic malignancies after stem cell transplantation. Bone Marrow Transplant. 33(Suppl. 1),S174 (2004).","journal-title":"Bone Marrow Transplant."},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.162"}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt.14.10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T01:58:18Z","timestamp":1715997498000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt.14.10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["10.2217\/imt.14.10"],"URL":"https:\/\/doi.org\/10.2217\/imt.14.10","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"value":"1750-743X","type":"print"},{"value":"1750-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2014-05-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}